Skip to main navigation
Who We Are
What We Stand For
Leadership
Advocacy/Unmet Need
Work With Us
Corporate Responsibility
Our Portfolio
RTGel® Technology
JELMYTO®
(mitomycin) for pyelocalyceal solution
Partnerships
Pipeline
Media & Investors
Media
Investors
News Releases
Events
Financials
Governance
Stocks
Reports
Resources
Connect
We strive to
put patients first
and preserve their future
possibilities
Investor Relations
Overview
News Releases
Events
Financials
Governance
Stock Info
Reports
Resources
UroGen Pharma ZUSDURI Approval Investor Call
Jun 13, 2025
8:30 AM EDT
Listen to webcast
Back
to top
